Next-generation Sequencing (NGS) Market

Next-generation Sequencing (NGS) Market by Product (NOVASEQ, NEXTSEQ, SEQUEL, NANOPORE), Consumables, Bioinformatics, Services (EXOME, RNA, DENOVO), Technology (ION, SMRT), Application (Diagnostics, Cancer), End User, Region - Global Forecast to 2025

Report Code: BT 2697 Nov, 2019, by marketsandmarkets.com

[216 Pages Report] The next-generation sequencing (NGS) market is projected to reach USD 24.4 billion by 2025 from USD 7.8 billion in 2019, at a CAGR of 20.9%., at a CAGR of 20.9%. The growth of this market is largely driven by the advancements in and declining costs of NGS platforms and the improving regulatory and reimbursement scenario for NGS-based diagnostic tests.

Next-Generation Sequencing (NGS) Market

The SBS segment accounted for the largest share of the NGS market, by technology, in 2018

On the basis of technology, the NGS market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, nanopore sequencing, and other sequencing technologies. In 2018, the SBS segment accounted for the largest share of the NGS market. The dominant market position of this segment is mainly due to the development of new and advanced NGS platforms and the increasing demand for Illumina’s systems, as it is the major provider of NGS platforms that use the SBS technology (including the HiSeq MiSeq series and NextSeq).

The diagnostics application segment accounted for the largest share of the NGS market in 2018

Based on application, the NGS market is segmented into diagnostics, drug discovery, agricultural & animal research, and other applications. Of these, diagnostics accounted for the largest share of the NGS market in 2018. The large share of this segment can be attributed to the growing number of new cancer cases across the globe, favorable reimbursement scenario for NGS-based tests in the US, and increasing focus of key market players on developing NGS-based products & services for cancer and NIPT.

The academic institutes & research centers end-user segment accounted for the largest share of the NGS market in 2018

On the basis of end user, the NGS market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. In 2018, the academic institutes & research centers segment accounted for the largest share of the NGS market. This can be attributed to the increasing number of collaborations between NGS market players and academic & research institutions, favorable funding scenario for genomics research across regions, and the development of cost-effective NGS products and services for researchers.

North America accounted for the largest share of the NGS market in 2018

North America accounted for the largest share of the NGS market in 2018, followed by Europe. This can primarily be attributed to factors such as the increasing applications of NGS in diagnostics and genomics research, the availability of research funding, and the development of NGS data analysis solutions.

Next-Generation Sequencing (NGS) Market

Key Market Players

Some of the prominent players in the NGS market are Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), BGI Group (China), PerkinElmer Inc. (US), Macrogen (South Korea), Hamilton Company (US), Lucigen (US), Oxford Nanopore Technologies (UK), Agilent Technologies, Inc. (US), and QIAGEN (Netherlands).

An analysis of the market developments between 2016 and 2019 revealed that product launches & enhancements, partnerships, agreements, and acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the NGS market. Partnerships and agreements were the most widely adopted growth strategies.

Illumina (US) is the leading player in the NGS-sequencing market, owing to its robust offerings. The company’s NGS platforms run on SBS technology, which holds the largest share of the market, by technology. Illumina’s products include a wide range of sequencing, genotyping, gene expression, molecular diagnostic platforms, consumables, and services. Over the past three years, Illumina has launched several products in the market. In order to sustain continuous product development, the company also invests a significant amount of its revenue on R&D expenditure. Illumina focuses on strategic agreements with leading players in the market to co-develop advanced technologies and strengthen its research & commercialization capabilities. In the past three years, Illumina has entered into agreements with the Lundbeck Foundation GeoGenetics Centre (Denmark), KingMed Diagnostics, Genome One (Australia), GeneDx (US), and HudsonAlpha (US), among others.

Thermo Fisher Scientific (US) offers sequencers that run on its Ion semiconductor technology (the second-largest segment of the technologies market). The company also offers reagents & consumables, software, and services for NGS research. Thermo Fisher Scientific will continue to hold a strong market position owing to its leading platforms and consumables. The firm also has a significant geographical presence.

Scope of the Report

Report Metric

Details

Market size available for years

2017–2025

Base year considered

2018

Forecast period

2019–2025

Forecast units

Value (USD)

Segments covered

Product & service, technology, application, end user, and region

Geographies covered

North America (US and Canada), Europe (Germany, France, UK, Spain, Italy, Netherlands, and the Rest of Europe), Asia Pacific (China, Japan, Australia, India, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of LATAM), and the Middle East and Africa

Companies covered

Major players covered include Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), BGI Group (China), PerkinElmer Inc. (US), Macrogen (South Korea), Hamilton Company (US), Lucigen (US), Intrexon Bioinformatics GmbH (Germany), Partek Incorporated (US), DNASTAR, Inc. (US), DNAnexus (US), SciGenom Labs Pvt. Ltd. (India), GENEWIZ (US), Takara Bio Inc. (Japan), Eurofins Scientific (Luxembourg), 10x Genomics (US), F. Hoffmann-La Roche Ltd. (Switzerland), Becton Dickinson and Company (US), Danaher (US), Lexogen GmbH (Austria), Tecan Trading AG (Switzerland), Zymo Research (US), Oxford Nanopore Technologies (UK), Agilent Technologies, Inc. (US), and QIAGEN (Netherlands)

This research report categorizes the NGS market into the following segments and subsegments:

By Product & Service

  • Introduction
  • Presequencing Products & Services
    • Library Preparation & Target Enrichment
    • Quality Control
  • NGS consumables
  • NGS Platforms
    • Illumina
      • HiSeq Systems
      • HiSeq X Ten & HiSeq X Five
      • MiSeq Systems
      • NextSeq Systems
      • MiniSeq Systems
      • NovaSeq Systems
      • iSeq 100 Systems
    • Thermo Fisher Scientific
      • Ion PGM Systems
      • Ion Proton Systems
      • Ion GeneStudio S5 Systems
    • Pacific Biosciences
      • PacBio RS II Systems
      • Sequel Systems
    • Oxford Nanopore Technologies
    • Other NGS Platforms
  • Services for NGS Platforms
  • Sequencing Services
    • Exome & Targeted Resequencing and Custom Panels
    • RNA-Seq
    • Whole-genome Sequencing and De Novo Sequencing
    • Other Sequencing Services
  • Bioinformatics
    • Data Analysis Software & Workbenches
    • Data Analysis Services
    • Storage, Management, and Cloud Computing Solutions

By Technology

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Single-molecule Real-time Sequencing
  • Nanopore Sequencing
  • Other Sequencing Technologies

By Application

  • Diagnostics
    • Cancer Diagnostics
    • Reproductive Health Diagnostics
    • Infectious Disease Diagnostics
    • Other Diagnostic Applications
  • Drug Discovery
  • Agriculture & Animal Research
  • Other Applications

By End User

  • Academic Institutes & Research Centers
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Netherlands
    • RoE
  • Asia Pacific
    • China
    • Japan
    • Australia
    • India
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
    • RoLATAM
  • Middle East and Africa

Key Questions Addressed by the Report:

  • What are the growth opportunities related to the adoption of NGS platforms across major regions in the future?
  • Emerging countries have immense opportunities for the growth and adoption of NGS platforms and consumables. Will this scenario continue in the next five years?
  • Where will the advancements in products offered by various companies take the industry in the mid- to long-term?
  • What are the newest trends and advancements in the NGS market?
  • How will the use of NGS in diagnostics impact the overall adoption and industry of NGS products?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 20)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 24)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Breakdown of Primaries
                    2.1.2.2 Key Data From Primary Sources
    2.2 Market Size Estimation
           2.2.1 Product-Based Market Estimation
           2.2.2 Application-Based Market Size Estimation
    2.3 Market Breakdown & Data Triangulation
    2.4 Assumptions for the Study

3 Executive Summary (Page No. - 33)

4 Premium Insights (Page No. - 37)
    4.1 Next-Generation Sequencing Market Overview
    4.2 Next-Generation Sequencing Market, By Product & Service, 2019 vs 2025 (USD Million)
    4.3 Next-Generation Sequencing Market Share, By Technology, 2019 vs 2025
    4.4 Next-Generation Sequencing Market, By Application, 2019 vs 2025 (USD Million)
    4.5 Next-Generation Sequencing Market, By End User, 2019 vs 2025 (USD Million)
    4.6 Next-Generation Sequencing Market: Geographical Snapshot

5 Market Overview (Page No. - 40)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Advancements in NGS Platforms
                               5.2.1.1.1 Iseq
                               5.2.1.1.2 Ion Genestudio S5
                    5.2.1.2 Declining Costs
                    5.2.1.3 Improving Regulatory & Reimbursement Scenario for NGS-Based Diagnostic Tests
           5.2.2 Restraints
                    5.2.2.1 End-User Budget Constraints in Developing Nations
           5.2.3 Opportunities
                    5.2.3.1 Government & Private Support for Large-Scale Sequencing
                    5.2.3.2 Application of NGS in Precision Medicine & Molecular Diagnostics
                    5.2.3.3 NGS Data Analysis Using Big Data
           5.2.4 Challenges
                    5.2.4.1 Interpretation of Complex Data From NGS Platforms
                    5.2.4.2 Ethical Issues
           5.2.5 Industry Trends
                    5.2.5.1 Development of Portable Sequencing Technology
                    5.2.5.2 Partnerships and Collaborations for Technological Advancements in NGS

6 Next-Generation Sequencing Market, By Product & Service (Page No. - 48)
    6.1 Introduction
    6.2 Presequencing Products & Services/Sample Preparation
           6.2.1 Sample Preparation is the First Step of an NGS Workflow
                    6.2.1.1 Library Preparation & Target Enrichment
    6.3 NGS Consumables
           6.3.1 Growing Number of Sequencing Procedures to Propel the Demand for NGS Consumables
    6.4 NGS Platforms
           6.4.1 Illumina
                    6.4.1.1 Increasing Installations of Sequencers to Propel Market Growth
                    6.4.1.2 Hiseq Systems
                    6.4.1.3 Hiseq X Ten & Hiseq X Five
                    6.4.1.4 Miseq Systems
                    6.4.1.5 Nextseq Systems
                    6.4.1.6 Miniseq Systems
                    6.4.1.7 Novaseq Systems
                    6.4.1.8 Iseq 100 Systems
           6.4.2 Pacific Biosciences
                    6.4.2.1 Pacific Biosciences Systems are Restricted to Smaller Genomes and Applications Where Long Reads are Required
                    6.4.2.2 Pacbio Rs Ii
                    6.4.2.3 Sequel Systems
           6.4.3 Thermo Fisher Scientific
                    6.4.3.1 Ion PGM Systems Contributed to the Largest Share of the Company’s Revenue in the NGS Platforms Market
                    6.4.3.2 Ion PGM Systems
                    6.4.3.3 Ion Proton
                    6.4.3.4 Ion Genestudio S5
           6.4.4 Oxford Nanopore Technologies
                    6.4.4.1 Sequencers Offered By Oxford Nanopore Technologies are Expected to Witness Significant Adoption in the Coming Years
           6.4.5 Other NGS Platforms
    6.5 Services for NGS Platforms
           6.5.1 Increasing Installation of NGS Platforms to Support Market Growth
    6.6 Sequencing Services
           6.6.1 Exome & Targeted Resequencing and Custom Panels
                    6.6.1.1 Development of Technologically Advanced NGS Products and Services to Propel Market Growth
           6.6.2 Rna-Seq
                    6.6.2.1 Launch of Advanced Rna Products and Services to Drive Market Growth
           6.6.3 Whole-Genome Sequencing & De Novo Sequencing
                    6.6.3.1 Reducing Whole-Genome Sequencing Costs to Propel the Growth of This Segment
           6.6.4 Other Sequencing Services
    6.7 Bioinformatics
           6.7.1 NGS Data Analysis Software & Workbenches
           6.7.2 NGS Data Analysis Services
                    6.7.2.1 Availability of Data Analysis Services is the Major Factor Supporting the Growth of This Market.
           6.7.3 NGS Storage, Management, and Cloud Computing Solutions
                    6.7.3.1 Launch of Cloud-Based Solutions to Drive the Market

7 Next-Generation Sequencing Market, By Technology (Page No. - 73)
    7.1 Introduction
    7.2 Sequencing By Synthesis
           7.2.1 SBS Technology Enables the Highest Production of Base Pairs in A Short Period of Time
    7.3 Ion Semiconductor Sequencing
           7.3.1 Ion Semiconductor Sequencing Platforms Possess High-Throughput Capabilities
    7.4 Single-Molecule Real-Time Sequencing
           7.4.1 SMRT Sequencing Produces Results in A Short Time and at Lower Costs
    7.5 Nanopore Sequencing
           7.5.1 Nanopore Sequencing is the Only Sequencing Technology With Direct Rna-Sequencing Capabilities
    7.6 Other Sequencing Technologies

8 Next-Generation Sequencing Market, By Application (Page No. - 80)
    8.1 Introduction
    8.2 Diagnostics
           8.2.1 Cancer Diagnostics
                    8.2.1.1 Growing Number of New Cancer Cases to Propel Market Growth
           8.2.2 Infectious Disease Diagnostics
                    8.2.2.1 Lack of Awareness About NGS-Based Diagnosis for Infectious Diseases to Hamper Market Growth
           8.2.3 Reproductive Health Diagnostics
                    8.2.3.1 Increasing Awareness About the Benefits of NIPT to Propel Market Growth
           8.2.4 Other Diagnostic Applications
    8.3 Drug Discovery
           8.3.1 Increasing Use of NGS During Clinical Trials for Drug Discovery to Support Market Growth
    8.4 Agricultural & Animal Research
           8.4.1 Growing Funding & Support for Animal & Plant Genomics Research to Drive Market Growth
    8.5 Other Applications

9 Next-Generation Sequencing Market, By End User (Page No. - 91)
    9.1 Academic Institutes & Research Centers
           9.1.1 Development of Cost-Effective NGS Products and Services for Researchers to Propel Market Growth
    9.2 Hospitals & Clinics
           9.2.1 Development of Advanced NGS-Based Diagnostic Solutions to Enhance the Adoption of NGS in Hospitals and Clinics
    9.3 Pharmaceutical & Biotechnology Companies
           9.3.1 Growing Agreements and Collaborations Between NGS Market Players and Pharma Biotech Firms to Fuel Market Growth
    9.4 Other End Users

10 Next-Generation Sequencing Market, By Region (Page No. - 96)
     10.1 Introduction
     10.2 North America
             10.2.1 US
                        10.2.1.1 Growing R&D Activities in the US to Drive Market Growth
             10.2.2 Canada
                        10.2.2.1 Increasing Government Initiatives in Genomics Research Will Boost the Adoption of NGS Technology
     10.3 Europe
             10.3.1 Germany
                        10.3.1.1 Germany Dominates the European NGS Market
             10.3.2 France
                        10.3.2.1 Government Initiatives to Support Genomics Research—Major Factor Driving Market Growth in France
             10.3.3 UK
                        10.3.3.1 Favorable Funding Scenario for Genomics Research in the Country to Support the Adoption of NGS
             10.3.4 Spain
                        10.3.4.1 Increasing Number of Conferences Focusing on NGS to Support Market Growth in Spain
             10.3.5 Italy
                        10.3.5.1 Favorable Funding Scenario to Drive the NGS Market in Italy
             10.3.6 Netherlands
                        10.3.6.1 Increasing Focus of Market Players on Developing NGS Technologies to Support Market Growth
             10.3.7 RoE
     10.4 Asia Pacific
             10.4.1 China
                        10.4.1.1 China to Register the Highest Growth in the APAC NGS Market
             10.4.2 Japan
                        10.4.2.1 High Incidence of Genetic Disorders in the Country has Resulted in the Increased Adoption of NGS
             10.4.3 Australia
                        10.4.3.1 Increasing Public and Private Initiatives to Support the Adoption of NGS Technologies in Australia
             10.4.4 India
                        10.4.4.1 Growing Prevalence of Target Diseases in India to Support Market Growth
             10.4.5 Rest of Asia Pacific
     10.5 Latin America
             10.5.1 Brazil
                        10.5.1.1 High Prevalence of Hiv in Brazil to Drive the Demand for NGS
             10.5.2 Mexico
                        10.5.2.1 Economic Growth in Mexico to Support the Growth of the NGS Market
             10.5.3 Rest of Latin America
     10.6 Middle East & Africa
             10.6.1 Lack of Infrastructure for Genomics Research to Hamper the Growth of the NGS Market in the MEA

11 Competitive Landscape (Page No. - 134)
     11.1 Introduction
     11.2 Competitive Leadership Mapping
             11.2.1 Terminology/Nomenclature
                        11.2.1.1 Visionary Leaders
                        11.2.1.2 Innovators
                        11.2.1.3 Dynamic Differentiators
                        11.2.1.4 Emerging Companies
     11.3 Competitive Scenario (2015-2019)
     11.4 NGS Market Ranking, By Top Three Market Players (2018)

12 Company Profiles (Page No. - 142)
(Business Overview, Products Offered, Recent Developments, MnM View, SWOT Analysis)*
     12.1 Agilent Technologies, Inc.
     12.2 Illumina, Inc.
     12.3 Qiagen N.V.
     12.4 F. Hoffmann-La Roche AG
     12.5 Thermo Fisher Scientific, Inc.
     12.6 Genewiz (A Part of Brooks Automation)
     12.7 BGI Group
     12.8 Perkinelmer
     12.9 Eurofins Scientific
     12.10 Macrogen.
     12.11 Oxford Nanopore Technologies
     12.12 10x Genomics
     12.13 Takara Bio
     12.14 Zymo Research
     12.15 Nugen Technologies (Part of Tecan Trading AG)
     12.16 Hamilton Company
     12.17 Beckman Coulter (A Subsidiary of Danaher)
     12.18 Becton, Dickinson and Company
     12.19 Genotypic Technology
     12.20 Lucigen Corporation

*Business Overview, Products Offered, Recent Developments, MnM View, SWOT Analysis Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 207)
     13.1 Discussion Guide
     13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.3 Available Customizations
     13.4 Related Reports
     13.5 Author Details


List of Tables (121 Tables)

Table 1 Partnerships & Collaborations, 2017–2019
Table 2 Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)
Table 3 Presequencing Products & Services Market, By Region, 2017–2025 (USD Million)
Table 4 Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)
Table 5 Library Preparation & Target Enrichment Market, By Region, 2017–2025 (USD Million)
Table 6 Quality Control Market, By Region, 2017–2025 (USD Million)
Table 7 NGS Consumables Market, By Region, 2017–2025 (USD Million)
Table 8 NGS Platforms Market, By Type, 2017–2025 (USD Million)
Table 9 NGS Platforms Market, By Region, 2017–2025 (USD Million)
Table 10 Illumina Platforms Market, By Type, 2017–2025 (USD Million)
Table 11 Illumina NGS Platforms Market, By Region, 2017–2025 (USD Million)
Table 12 Hiseq Systems Market, By Region, 2017–2025 (USD Million)
Table 13 Hiseq X Ten & Hiseq X Five Market, By Region, 2017–2025 (USD Million)
Table 14 Miseq Systems Market, By Region, 2017–2025 (USD Million)
Table 15 Nextseq Systems Market, By Region, 2017–2025 (USD Million)
Table 16 Miniseq Systems Market, By Region, 2017–2025 (USD Million)
Table 17 Novaseq Systems Market, By Region, 2017–2025 (USD Million)
Table 18 Iseq 100 Systems Market, By Region, 2017–2025 (USD Million)
Table 19 Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)
Table 20 Pacific Biosciences NGS Platforms Market, By Region, 2017–2025 (USD Million)
Table 21 Pacbio Rs Ii Systems Market, By Region, 2017–2025 (USD Million)
Table 22 Sequel Systems Market, By Region, 2017–2025 (USD Million)
Table 23 Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)
Table 24 Thermo Fisher Scientific NGS Platforms Market, By Region, 2017–2025 (USD Million)
Table 25 Ion PGM Platforms Market, By Region, 2017–2025 (USD Million)
Table 26 Ion Proton Systems Market, By Region, 2017–2025 (USD Million)
Table 27 Ion Genestudio S5 Platforms Market, By Region, 2017–2025 (USD Million)
Table 28 Oxford Nanopore Technologies NGS Platforms Market, By Region, 2017–2025 (USD Million)
Table 29 Other NGS Platforms Market, By Region, 2017–2025 (USD Million)
Table 30 Services for NGS Platforms Market, By Region, 2017–2025 (USD Million)
Table 31 NGS Sequencing Services Market, By Type, 2017–2025 (USD Million)
Table 32 NGS Sequencing Services Market, By Region, 2017–2025 (USD Million)
Table 33 NGS Bioinformatics Market, By Product & Service, 2017–2025 (USD Million)
Table 34 NGS Bioinformatics Market, By Region, 2017–2025 (USD Million)
Table 35 Next-Generation Sequencing Technologies, By Company
Table 36 Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)
Table 37 Sequencing By Synthesis Market, By Region, 2017–2025 (USD Million)
Table 38 Ion Semiconductor Sequencing Market, By Region, 2017–2025 (USD Million)
Table 39 Single-Molecule Real-Time Sequencing Market, By Region, 2017–2025 (USD Million)
Table 40 Nanopore Sequencing Market, By Region, 2017–2025 (USD Million)
Table 41 Other Sequencing Technologies, By Region, 2017–2025 (USD Million)
Table 42 Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 43 Next-Generation Sequencing Market for Diagnostics, By Type, 2017–2025 (USD Million)
Table 44 Next-Generation Sequencing Market for Diagnostics, By Region, 2017–2025 (USD Million)
Table 45 Next-Generation Sequencing Market for Agricultural & Animal Research, By Region, 2016–2024 (USD Million)
Table 46 Next-Generation Sequencing Market for Other Applications, By Region, 2016–2024 (USD Million)
Table 47 Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)
Table 48 Next-Generation Sequencing Market for Academic Institutes & Research Centers, By Region, 2017–2025 (USD Million)
Table 49 Next-Generation Sequencing Market for Hospitals & Clinics, By Region, 2017–2025 (USD Million)
Table 50 Next-Generation Sequencing Market for Pharmaceutical & Biotechnology Companies, By Region, 2017–2025 (USD Million)
Table 51 Next-Generation Sequencing Market for Other End Users, By Region, 2017–2025 (USD Million)
Table 52 Next-Generation Sequencing Market, By Region, 2017–2025 (USD Million)
Table 53 North America: Next-Generation Sequencing Market, By Country, 2017–2025 (USD Million)
Table 54 North America: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)
Table 55 North America: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)
Table 56 North America: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)
Table 57 North America: Illumina Platforms Market, By Type, 2017–2025 (USD Million)
Table 58 North America: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)
Table 59 North America: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)
Table 60 North America: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)
Table 61 North America: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 62 North America: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)
Table 63 US: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 64 Canada: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 65 Europe: Next-Generation Sequencing Market, By Country, 2017–2025 (USD Million)
Table 66 Europe: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)
Table 67 Europe: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)
Table 68 Europe: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)
Table 69 Europe: Illumina Platforms Market, By Type, 2017–2025 (USD Million)
Table 70 Europe: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)
Table 71 Europe: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)
Table 72 Europe: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)
Table 73 Europe: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 74 Europe: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)
Table 75 Germany: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 76 France: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 77 UK: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 78 Spain: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 79 Italy: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 80 Netherlands: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 81 RoE: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 82 Asia Pacific: Next-Generation Sequencing Market, By Country, 2017–2025 (USD Million)
Table 83 Asia Pacific: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)
Table 84 Asia Pacific: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)
Table 85 Asia Pacific: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)
Table 86 Asia Pacific: Illumina Platforms Market, By Type, 2017–2025 (USD Million)
Table 87 Asia Pacific: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)
Table 88 Asia Pacific: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)
Table 89 Asia Pacific: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)
Table 90 Asia Pacific: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 91 Asia Pacific: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)
Table 92 China: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 93 Japan: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 94 Australia: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 95 India: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 96 RoAPAC: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 97 Latin America: Next-Generation Sequencing Market, By Country, 2017–2025 (USD Million)
Table 98 Latin America: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)
Table 99 Latin America: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)
Table 100 Latin America: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)
Table 101 Latin America: Illumina Platforms Market, By Type, 2017–2025 (USD Million)
Table 102 Latin America: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)
Table 103 Latin America: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)
Table 104 Latin America: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)
Table 105 Latin America: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 106 Latin America: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)
Table 107 Brazil: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 108 Mexico: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 109 RoLA: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 110 MEA: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)
Table 111 MEA: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)
Table 112 MEA: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)
Table 113 MEA: Illumina Platforms Market, By Type, 2017–2025 (USD Million)
Table 114 MEA: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)
Table 115 MEA: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)
Table 116 MEA: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)
Table 117 MEA: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 118 MEA: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)
Table 119 New Product Launches
Table 120 Acquisitions
Table 121 Partnerships, Agreements, and Collaborations


List of Figures (39 Figures)

Figure 1 Next-Generation Sequencing Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 NGS Market: Product-Based Estimation
Figure 5 NGS Platforms Market: Product-Based Estimation
Figure 6 NGS Market: Application-Based Estimation
Figure 7 NGS Market: Data Triangulation
Figure 8 Next-Generation Sequencing Market, By Product & Service, 2019 vs 2025 (USD Million)
Figure 9 Next-Generation Sequencing Market, By Technology, 2019 vs 2025 (USD Million)
Figure 10 Next-Generation Sequencing Market Share, By Application, 2019 vs 2025
Figure 11 Next-Generation Sequencing Market Share, By End User, 2019 vs 2025
Figure 12 Next-Generation Sequencing Market: Geographical Snapshot
Figure 13 Increasing Applications of NGS in Diagnostics and Genomics Research to Drive Market Growth
Figure 14 NGS Consumables to Dominate the NGS Market During the Forecast Period
Figure 15 Sequencing By Synthesis to Hold the Largest Share of the Market During the Forecast Period
Figure 16 Diagnostic Applications to Hold the Largest Share of the NGS Market in 2019
Figure 17 Academic Institutes & Research Centers to Hold the Largest Share of the NGS Market in 2019
Figure 18 China is Expected to Grow at the Highest CAGR During the Forecast Period
Figure 19 NGS Market: Drivers, Restraints, Opportunities, and Challenges
Figure 20 Cost of Human Whole-Genome Sequencing, 2001–2019
Figure 21 Data Production During Human Whole-Genome Sequencing, 2001–2019
Figure 22 Funding for Cancer Research in the US (2018)
Figure 23 Number of Pubmed Research Publications on NGS-Based Drug Discovery, 2008–2017
Figure 24 North America: Next-Generation Sequencing Market Snapshot
Figure 25 Asia Pacific: Next-Generation Sequencing Market Snapshot
Figure 26 NGS Market, Competitive Leadership Mapping, 2018 (Overall Market)
Figure 27 NGS Market, Competitive Leadership Mapping, 2018 (Sme/Start-Ups)
Figure 28 Key Developments in the NGS Market, 2016–2019
Figure 29 Illumina Held the Leading Position in the NGS Market as of 2018
Figure 30 Illumina Held the Leading Position in the NGS Platform Market as of 2018
Figure 31 Agilent Technologies: Company Snapshot (2018)
Figure 32 Illumina: Company Snapshot (2018)
Figure 33 Qiagen N.V. : Company Snapshot (2018)
Figure 34 Roche: Company Snapshot (2018)
Figure 35 Thermo Fisher Scientific: Company Snapshot (2018)
Figure 36 Brooks Automation, Inc.: Company Snapshot (2018)
Figure 37 Perkin Elmer: Company Snapshot (2018)
Figure 38 Takara Bio: Company Snapshot (2018)
Figure 39 Tecan: Company Snapshot (2018)

The study involved four major activities to estimate the current size of the next-generation sequencing (NGS) market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Businessweek, and Factiva) were referred to in order to identify and collect information for this study.

Primary Research

The NGS market comprises several stakeholders such as NGS equipment manufacturers, NGS sequencing service companies, NGS bioinformatics/data analysis companies, research laboratories and academic institutes, venture capitalists and other government funding organizations, research and consulting firms, healthcare institutions (hospitals and diagnostic clinics), pharmaceutical and biotechnology companies, contract manufacturing organizations (CMOs), and contract research organizations (CROs).

The demand side of this market is characterized by the significant use of NGS platforms due to factors such as advancements and declining costs in NGS platforms and the improving regulatory and reimbursement scenario for NGS-based diagnostic tests. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of primary respondents:

Next-Generation Sequencing (NGS) Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the NGS market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the NGS industry.

Report Objectives

  • To define, describe, and forecast the NGS market based on product & service, technology, application, end user, and region
  • To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges), along with current trends
  • To strategically analyze micromarkets with respect to their individual growth trends, future prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the revenue of market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players and comprehensively analyze their market shares and core competencies (captured in terms of the developments reported and strategies adopted by them to maintain their market positions)
  • To track and analyze competitive developments such as product launches, agreements, partnerships, collaborations, mergers & acquisitions, and R&D activities in the NGS market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

  • Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of the five major companies
  • Company Information: Detailed analysis and profiling of additional market players (Up to 5)
Report Code
BT 2697
Published ON
Nov, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Next-generation Sequencing (NGS) Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home